Vanguard Capital Management
ALXO icon

Vanguard Capital Management’s ALX Oncology ALXO Stock Holding History

Vanguard Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
4,973,436
+793,700
+19% +$1.42M ﹤0.01% 2797
2026
Q1 		$8.38M Buy
+4,179,736
New +$7.96M ﹤0.01% 2830

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management's ALXO Position: Q2 2026 in Review

Vanguard Capital Management increased its ALX Oncology (ALXO) stake by 19% in Q2 2026, buying an estimated $1.42M and bringing the position to 4,973,436 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

Vanguard Capital Management first reported a position in ALXO in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Vanguard Capital Management held 4,973,436 shares of ALX Oncology worth $10.3M as of Q2 2026.
  • Vanguard Capital Management bought 793,700 ALX Oncology shares in Q2 2026, an estimated $1.42M.
  • ALX Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2797 holding.
  • Vanguard Capital Management first reported a position in ALX Oncology in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.